Gastric cancers, with gastric adenocarcinoma (GAC) as the most common histological type,
impose a considerable global health burden. Although the screening strategies for early …

The treatment of advanced gastric cancer is essentially palliative. Therapy's main aim in this
common group of patients with unresectable or metastatic disease is to achieve good …

Metastatic gastric cancer remains a non-curative disease. Palliative chemotherapy has been
demonstrated to prolong survival without quality of life compromise. Many single-agents and …

China is one of the countries with the highest incidence of gastric cancer. There are
differences in epidemiological characteristics, clinicopathological features, tumor biological …

Over the last decade, our understanding of the mechanisms underlying immune modulation
has greatly improved, allowing for the development of multiple therapeutic approaches that …

Gastric cancer is the second most common of cancer-related deaths worldwide. In the
majority of cases gastric cancer is advanced at diagnosis and although medical and surgical …

Gastric cancer incidence and mortality has fallen dramatically over the last 50 years in many
regions, but remains the second most common cancer worldwide. Despite a marked decline …

The clinical criteria for assessment of response to nonsurgical treatment of gastric cancer
can be categorized under six headings: patient status at the start of therapy, description of …

Recently, many strategies have been reported for the effective treatment of gastric cancer.
However, the strategy for treating stage IV gastric cancer remains controversial. Conducting …

Gastric cancer (GC) is defined as the primary epithelial malignancy derived from the
stomach, and it is a complicated and heterogeneous disease with multiple risk factors …